Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OmegaVet
Tampa, Florida, United Statesomegavet.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
OmegaVet is a veterinary pharmaceutical company dedicated to the development and commercialization of innovative therapeutic solutions for companion animals. The company focuses on addressing unmet medical needs in pets, particularly in the areas of chronic pain management, inflammatory diseases, and dermatology. By leveraging advancements in human biotechnology, OmegaVet aims to translate cutting-edge science into safe and effective treatments for dogs and cats. Their current research efforts are centered on novel modalities, including targeted biologics and small molecule inhibitors, to improve the quality of life for aging and diseased pets.
- Therapeutic areas
- RheumatologyDermatologyNeurology
- Modalities
- Small moleculeBiologicPeptides
- Industry
- Veterinary
Beyond the preview
Go deeper on OmegaVet.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OmegaVet.